Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

BB114814 Inhibitors

BB114814 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the protein BB114814, a protein implicated in various intracellular signaling pathways. BB114814 is known for its role in regulating several key cellular functions, including signal transduction, gene expression, and protein modification processes. By inhibiting the activity of BB114814, these compounds interfere with the normal signaling dynamics within the cell, affecting downstream effects such as protein phosphorylation and gene transcription. This can result in significant changes in cellular behavior, particularly in response to external stimuli that typically trigger these signaling pathways. BB114814 inhibitors are therefore valuable tools for probing the functional significance of this protein in cellular biology and for understanding the mechanisms that govern its regulatory role.

The chemical structures of BB114814 inhibitors are typically designed to interact with the active site or other critical domains of the BB114814 protein, disrupting its ability to participate in molecular interactions and enzymatic activities. The development of these inhibitors often involves extensive structure-activity relationship (SAR) studies to optimize the binding affinity, selectivity, and potency of the compounds. These inhibitors are used in biochemical research to explore the specific signaling pathways influenced by BB114814 and to elucidate its role in cellular processes such as proliferation, differentiation, and stress response. Through these studies, BB114814 inhibitors contribute to a deeper understanding of intracellular signaling networks and their regulation, offering insight into the molecular frameworks that support cellular function and adaptation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib inhibits CUB domain containing protein 3 by targeting protein tyrosine kinases which are upstream regulators, thereby preventing phosphorylation events that are necessary for the protein's functional activity.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib inhibits Src family kinases which are implicated in the activation process of CUB domain containing protein 3, thereby inhibiting its function.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib inhibits receptor tyrosine kinases that could be upstream of CUB domain containing protein 3, inhibiting its functional activity.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib inhibits epidermal growth factor receptor (EGFR) kinase activity, potentially reducing the activation of pathways that involve CUB domain containing protein 3, leading to its inhibition.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Lapatinib inhibits ErbB2 and EGFR, which may be involved in the signaling pathways that regulate CUB domain containing protein 3 activity, thus inhibiting it.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib inhibits multiple tyrosine protein kinases, potentially reducing signaling through pathways that involve CUB domain containing protein 3, thereby inhibiting its function.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Pazopanib inhibits vascular endothelial growth factor receptor (VEGFR) which could be involved in pathways that activate CUB domain containing protein 3, and thereby inhibit its activity.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Vandetanib selectively inhibits RET kinase, VEGFR, and EGFR, which could be part of the signaling network involving CUB domain containing protein 3, resulting in its inhibition.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib selectively inhibits EGFR tyrosine kinase, potentially disrupting signaling pathways that CUB domain containing protein 3 may be involved in, leading to its inhibition.